Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 20/4/2018
SIETES contiene 92261 citas

 
 
 1 a 7 de 7 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Torvinen-Kiskinen S, Tolppanen A-M, Koponen M, Tanskanen A, Tihonen J, Hartikainen S, Taipale H. Proton pump inhibitor use and risk of hip fractures among community-dwelling persons with Alzheimer's disease—a nested case-control study. Aliment Pharmacol Ther 2018;47:abril. [Ref.ID 102491]
2. Cita con resumen
Taipale H, Hamina A, Lampela P, Tanskanen A, Tiihonen J, Karttunen N, Tolpannen A-M, Hartikainen S. Is Alzheimer’s disease associated with previous opioid use?. Pain Med 2017:28 de agosto. [Ref.ID 102153]
3.Enlace a cita originalTiene citas relacionadas Cita con resumen
Taipale H, Tolppanen A-M, Koponen M, Tanskanen A, Lavikainen P, Sund R, Tiihonen J, Hartikainen S. Risk of pneumonia associated with incident benzodiazepine use among community- dwelling adults with Alzheimer disease. Can Med Assoc J 2017;189:E519-529. [Ref.ID 101524]
4. Cita con resumen
Torniainen M, Mittendorfer-Rutz E, Tanskanen A, Björkenstam C, Suvisaari J, Alexanderson K, Tiihonen J. Antipsychotic treatment and mortality in schizophrenia. Schizophrenia Bulletin 2014:24 de noviembre. [Ref.ID 98382]
5. Cita con resumen
Purhonen M, Koponen H, Tiihonen J, Tanskanen A. Outcome of patients after market withdrawal of thioridazine: a retrospective analysis in a nationwide cohort. Pharmacoepidemiol Drug Saf 2012;21:1227-31. [Ref.ID 93992]
6. Cita con resumen
Tiihonen J, Lönqvist J, Wahlbeck K, Klaukla T, Niskanen L, Tanskanen A, Haukla J. 11-year follow-up mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet 2009;374:620-7. [Ref.ID 86113]
7.Tiene citas relacionadas
Tuomilehto J, Jousilahti P, Tanskanen A, Pietinen P, Nissinen A. Sodium excretion and cardiovascular mortality. Authors' reply. Lancet 2001;358:666. [Ref.ID 58279]
Seleccionar todas
 
 1 a 7 de 7